Oxidative Stress in Diabetic Retinopathy: Pathogenic Mechanisms, Biomarkers and Clinical Implications
Antioxidants · 27.03.2026 · 15 (4) · 425
DOI: 10.3390/antiox15040425 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 27.03.2026. Verfasst von Caterina Toma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eye Clinic, University Hospital Maggiore Della Carità, 28100 Novara, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research, University of Eastern Piedmont.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is a leading cause of vision loss worldwide and represents a complex neurovascular complication of diabetes mellitus driven by chronic hyperglycemia. Increasing evidence identifies oxidative stress—defined as an imbalance between reactive oxygen species (ROS) production and antioxidant defenses—as a central pathogenic mechanism linking metabolic dysregulation to retinal injury. The retina is particularly vulnerable to oxidative damage due to its high metabolic demand, elevated oxygen consumption, and abundance of polyunsaturated fatty acids. Hyperglycemia activates multiple interconnected biochemical pathways, including the polyol and hexosamine pathways, protein kinase C signaling, advanced glycation end-product formation, and lipid peroxidation, all of which converge on excessive ROS production and mitochondrial dysfunction. Growing attention has focused on oxidative stress biomarkers as tools to characterize DR severity and progression. Elevated systemic markers of lipid, protein, and DNA oxidation, together with impaired antioxidant capacity, correlate with disease stage, while oxidative biomarkers detected in aqueous and vitreous humor reflect localized retinal injury. Importantly, oxidative stress biomarkers are also associated with functional outcomes, including best-corrected visual acuity and diabetic macular edema. Integration of systemic and ocular oxidative biomarkers with clinical staging may improve risk stratification and support personalized therapeutic strategies in DR.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Clinic, University Hospital Maggiore Della Carità, 28100 Novara, Italy.
- Laboratory of Physiology, Department of Translational Medicine, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.
- Department of Health Sciences, Università del Piemonte Orientale "Amedeo Avogadro", 28100 Novara, Italy.
ORCID-Profile: Caterina Toma, Mohammad Mostafa Ola Pour, Sakthipriyan Venkatesan, Elena Grossini
Förderung
- Italian Ministry of University and Research
- University of Eastern Piedmont
Zitieren
APA
Toma, C., Ferdeghini, D., Ola Pour, M. M., Venkatesan, S., De Cillà, S., & Grossini, E. (2026). Oxidative Stress in Diabetic Retinopathy: Pathogenic Mechanisms, Biomarkers and Clinical Implications. Antioxidants, 15(4), 425. https://doi.org/10.3390/antiox15040425
Vancouver
Toma C, Ferdeghini D, Ola Pour MM, Venkatesan S, De Cillà S, Grossini E. Oxidative Stress in Diabetic Retinopathy: Pathogenic Mechanisms, Biomarkers and Clinical Implications. Antioxidants. 2026;15(4):425. doi:10.3390/antiox15040425
BibTeX
@article{Toma2026,
author = {Toma, Caterina and Ferdeghini, Diego and Ola Pour, Mohammad Mostafa and Venkatesan, Sakthipriyan and De Cillà, Stefano and Grossini, Elena},
title = {Oxidative Stress in Diabetic Retinopathy: Pathogenic Mechanisms, Biomarkers and Clinical Implications},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {425},
doi = {10.3390/antiox15040425}
}
EUVIMED